Innovative Medicines Canada applauds the changes to OHIP+
OTTAWA, July 3, 2018 /CNW/ - Innovative Medicines Canada congratulates the new Ontario Minister of Health and Long-Term Care, Christine Elliott, on moving decisively to revamp OHIP+.
"It's a win-win for everyone," said Pamela Fralick, President of Innovative Medicines Canada, about the changes that will ensure that Ontario children and youth who are not covered by private benefits will continue to receive their eligible prescriptions free. "Ontarians under the age of 25 will continue to access the prescription drugs they need in a way that will be cost-effective for taxpayers."
Innovative Medicines Canada member companies play an important role in the health care system by bringing new and important treatments to Canada to improve the lives of Ontarians.
"We support a program that will have the best standard of care, and achieves the best health outcomes for patients by providing access to a full range of medicines, through both public and private insurance plans." added Ms. Fralick. "Innovative Medicines encourages the Ontario government to invest a portion of the savings into ensuring access to more life-changing medicines on its public plan."
As the province of Ontario moves forward with the changes to OHIP+, Innovative Medicines Canada looks forward to work with the provincial government to create the best possible access to prescription medicines for Ontarians and all Canadians.
About Innovative Medicines Canada
Innovative Medicines Canada is the national voice of Canada's innovative pharmaceutical industry. We advocate for policies that enable the discovery, development and commercialization of innovative medicines and vaccines that improve the lives of all Canadians. We support our members' commitment to being valued partners in the Canadian healthcare system.
SOURCE Innovative Medicines Canada